Medicare Rx Plans Must Calculate Beneficiary Spending Themselves – CMS
This article was originally published in The Pink Sheet Daily
The agency is considering two options for implementing rules regarding seniors’ true out-of-pocket spending (TrOOP) on prescription drugs. TrOOP cost-tracking could be the responsibility of either the Medicare drug plans or a CMS “facilitation contractor.”
You may also be interested in...
Proposed rules for Title I (Part D drug benefit) and Title II (Medicare Advantage) of the Medicare Modernization Act are unveiled at an HHS press conference. Final regs will be done by early 2005, "if not sooner," CMS Administrator McClellan says.
FDA asks Endo to disseminate “corrective messages” to doctors who received the violative promotional materials, which the agency says omit risk information and contain unsubstantiated effectiveness claims.
Studies that look for differences in efficacy among members of the same drug class are only performed when necessary for approval, CDER Office of Medical Policy Director Temple tells DIA. While questioning the introduction of "follow-on" compounds, Temple also highlights AstraZeneca's success in achieving a more optimal dose for Nexium.